Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Antiparasitics

Ceva to launch canine heartworm generic in US

French firm Ceva Santé Animale is launching MilbeGuard (milbemycin oxime) flavored tablets in the US.

Ceva Sante Animale Antiparasitics

Pharmgate launches generic feed additive in US cattle market

Pharmgate Animal Health has introduced Deracin (chlortetracycline) to control two of the most costly and challenging diseases in the US cattle industry.

Generics Antiparasitics

FDA requests drug label revision for antiparasitic resistance

The US FDA has requested animal drug companies to voluntarily revise product labels to add information about antiparasitic resistance.

FDA Policy & Regulation

Revolution Plus approval puts Zoetis 'six-in-one' cat antiparasitic on US market

Zoetis has gained US FDA approval for Revolution Plus (selamectin and sarolaner topical solution) – a monthly feline combination topical antiparasitic.

United States Zoetis

Animal Pharm, Stonehaven Consulting map out industry's innovative start-ups

A new collaborative report from Animal Pharm and Stonehaven Consulting has highlighted the leading start-up companies in the animal health space.

R&D Investments

EPRUMA unveils guidance for anthelmintic use in food-producing animals

The European Platform for the Responsible Use of Medicines in Animals (EPRUMA) has launched a new publication to tackle anthelmintic resistance.

Policy & Regulation Antiparasitics

Zoetis to market Revolution Plus in 2019, eyes more lifecycle innovation

Zoetis is to add to its Revolution (selamectin) canine parasiticide brand next year, by bringing a new product to market in the US.

Zoetis R&D

Boehringer assesses options as LongRange again receives CVMP negative opinion

European authorities have again recommended Boehringer Ingelheim's Longrange 50 mg/ml (eprinomectin) should not be approved.

Boehringer Ingelheim Animal Health Antiparasitics

Scientists discuss research, strategies against anthelmintic resistance

A group of 90 researchers from 30 countries have gathered to share research and discuss coordinating an approach to developing solutions for anthelmintic resistance. 

Research Antiparasitics

American Vanguard to save TyraTech from 'fragile financial situation' with purchase

US agricultural products business American Vanguard (AMVAC) is to acquire the shares in TyraTech that it did not already own.

M&A Antiparasitics

FDA warns of adverse drug events related to isoxazolines

The US FDA is alerting pet owners and veterinarians of the possible adverse neurological events to cats and dogs associated with isoxazoline flea and tick products.

FDA Antiparasitics

New Kansas City company to provide market with revenue-ready products

Covenant Animal Health Partners has been launched to focus on bringing animal health innovations to market.

R&D Companion Animals
See All